Testing a novel male contraceptive gel containing Nestorone and testosterone applied daily by the male partner in a global Phase 2 clinical trial evaluating the efficacy, safety and acceptability of the gel over a period of 52 weeks.
Project Country: United Kingdom
Embeddable Sustained Release Microneedles for Contraceptive Delivery
Supporting the development of a six-month contraceptive microarray patch by reviewing the applicator device, user studies, regulatory pathway, and preclinical activities.
Microarray Patches for HIV Pre-exposure Prophylaxis
Advancing the development of a microarray patch delivering cabotegravir for prevention of HIV infection for up to 4 weeks of protection.